Quick links


Whitepaper

Patient Engagement Experience – Add a Pinch of Perception, Sustainability, and Analytics to Your Existing Database and See the Difference

The world today is moving towards a proactive than reactive approach. Most pharmaceutical and medical device companies depend on expensive clinical and drug user databases that charge them hefty subscription fees for feeds that are mostly available in the public domain.

Key Takeaways:

  • The convergence of patient experience, perception, and decision-making process should be merged with the offerings and solutions.
  • With data convergence set to play a major role in PEP, wearables, learning, and development, marketing, app-based data, and salesforce data (from drug/product companies) will become integrated.
  • Dependency on fixed metrics on subscription-based databases will also lead to major failures of strategy.

To know more...


Related Topics

SGA Whitepaper Market Entry in 2023

Whitepapers

Market Entry in 2023: Why Must You Also Look at Markets...

Due to dollar fluctuations and the likelihood of market recession, investors and manufacturers of medical devices and pharma are exploring new opportunities...

SGA Whitepaper Blue Ocean Strategy

Whitepapers

The Blue Ocean Strategy in the Pharmaceutical Industry:...

Blue ocean refers to a new market that presents low competition, is less crowded, and is open to accommodate new innovations and marketing opportunities....

SGA Healthcare Whitepaper Healthcare Consulting & Analytics

Whitepapers

What Happens When You Invest in Healthcare Consulting and...

Healthcare providers who are struggling with high-volume complex data are feeling the need for assistance with data convergence and management. With...

VIEW MORE

We bring comprehensive data driven insights to everyone, everywhere